Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
D000818:Animals; D001392:Azocines / Q000494:pharmacology; D002264:Carboxylic Acids / Q000494:pharmacology; D002540:Cerebral Cortex / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism / Q000502:physiology*; D002852:Chromatography, Ion Exchange; D004220:Disulfides / Q000494:pharmacology; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism*; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors / Q000378:metabolism; D004558:Electric Stimulation; D004952:Esters / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D009638:Norepinephrine / Q000096:biosynthesis / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D014316:Tritium; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors / Q000494:pharmacology
D001392:Azocines; D002264:Carboxylic Acids; D004220:Disulfides; D004952:Esters; D008781:Methyltyrosines; D014316:Tritium; D006899:Mixed Function Oxygenases; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D004298:Dopamine; D009638:Norepinephrine